Journal Information
Vol. 40. Issue 3.
Pages 199-292 (July - September 2018)
Download PDF
More article options
Vol. 40. Issue 3.
Pages 199-292 (July - September 2018)
Scientific Comment
DOI: 10.1016/j.htct.2018.01.004
Open Access
Age and cytogenetic abnormalities
Cármino Antonio de Souza
Corresponding author

Correspondence to: Universidade Estadual de Campinas (UNICAMP), Rua Carlos Chagas, 450 Cidade Universitária “Prof. Zeferino Vaz” Distrito de Barão Geraldo, Campinas, SP, Brazil.
Universidade Estadual de Campinas (Unicamp), Campinas, SP, Brazil
Related content
hematol Transfus Cell Ther 2018;40:200-610.1016/j.htct.2017.10.001
Angelica de Souza Batista Maia Alves, Fernanda Barbi Bataglia, Luciene de Oliveira Conterno, Rosimeire Segato, Spencer Luiz Marques Payão
This item has received

Under a Creative Commons license
Article information
Full Text
Download PDF
Full Text

In this issue, the Hematology, Transfusion and Cell Therapy Journal is publishing a paper of Alves et al. coordinated by Dr. Payão from the Medical School of Marilia, São Paulo, Brazil, discussing an interesting aspect of cytogenetic abnormalities (CA) in respect to aging. In a retrospective analysis of a large sample (746 patients) over 18 years of observation and including several types of onco-hematological diseases in patients of all ages, the authors investigated the influence of age on the frequency of CA.1 The authors found a higher frequency of hematological malignancies among elderly patients, about 51%, followed by adult (38%) and young patients (about of 11%). The authors reported that “it is possible to conclude that failures in genomic mechanisms and hematopoiesis with aging lead to the formation of cells with the chromosomal alterations found in hematological malignancies”. From the 1960s with the description of Philadelphia chromosome in chronic myeloid leukemia (CML),2 CA have been recognized as important prognostic factors in acute promyelocytic leukemia (APL), acute myeloid leukemia (AML), myelodysplastic syndromes (MDS) and in a great number of onco-hematological diseases and syndromes.3 These abnormalities became diagnostic and prognostic markers and they are very useful in the monitoring of minimal residual disease (MDR). Data from the literature supports the higher frequency of onco-hematological diseases in the elderly population.4 Particularly in AML, elderly patients have a poor prognosis compared to young and adult patients, despite the development of different therapeutic approaches. The authors emphasize that the higher aggressiveness in the elderly is probably due to bone marrow and immune system impairment. Genomic and somatic mutations, inadequate cytokine production, and impairment of modulation and response to stimuli are among the factors associated with age.5 The paper by Alves et al. presents very interesting data and discussion about the influence and mechanisms associated to frequency, gender, diagnosis and prognosis of onco-hematological diseases and aging.1 Moreover, we can see the most frequent CA observed by the authors in a single Brazilian University Laboratory.

Conflicts of interest

The authors declare no conflicts of interest.

A.S. Alves, F.B. Bataglia, L.O. Conterno, R. Segato, S.L. Payão.
Epidemiological and cytogenetic profiles of patients with hematological malignancies and their relationship with aging.
Hematol Transfus Cell Ther, 40 (2018), pp. 201-207
P.C. Nowell.
Discovery of the Philadelphia chromosome: a personal perspective.
J Clin Invest, 117 (2007), pp. 2033-2035
D.A. Arber, A. Orazi, R. Hasserjian, J. Thiele, M.J. Borowitz, M.M. Le Beau, et al.
The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Blood, 127 (2016), pp. 2391-2405
C.C. Laurie, C.A. Laurie, K. Rice, K.F. Doheny, L.R. Zelnick, C.P. McHugh, et al.
Detectable clonal mosaicism from birth to old age and its relationship to cancer.
Nat Genet, 44 (2012), pp. 642-650
E. Sahin, R.A. Depinho.
Linking functional decline of telomeres, mitochondria and stem cells during ageing.
Nature, 464 (2010), pp. 520-528

See paper by Angelica de Souza Batista Maia Alves et al. on pages 201–207.

Copyright © 2018. Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular
Hematology, Transfusion and Cell Therapy

Subscribe to our newsletter

Article options
en pt
Cookies policy Política de cookies
To improve our services and products, we use "cookies" (own or third parties authorized) to show advertising related to client preferences through the analyses of navigation customer behavior. Continuing navigation will be considered as acceptance of this use. You can change the settings or obtain more information by clicking here. Utilizamos cookies próprios e de terceiros para melhorar nossos serviços e mostrar publicidade relacionada às suas preferências, analisando seus hábitos de navegação. Se continuar a navegar, consideramos que aceita o seu uso. Você pode alterar a configuração ou obter mais informações aqui.